QT Imaging Holdings, Inc.

QTI ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022
Revenue $18.9M $4.9M $0 $0
Cost of Revenue $10.3M $2.2M $135.0K —
Gross Profit $8.6M $2.6M $-94.6K —
Gross Margin 45.4% 54.1% — —
Operating Expenses
Research & Development $3.9M $3.3M $1.5M —
SG&A Expense $9.1M $11.6M $3.4M $4.3M
Operating Income $-4.4M $-12.2M $-5.0M $-4.3M
Operating Margin -23.4% -249.6% — —
Interest Expense — — $219.7K $23.1K
Pretax Income $-21.1M $-9.0M $-6.1M $-2.3M
Income Tax Expense $-1.0K $-16.0K $1.6K $486.6K
Net Income $-21.1M $-9.0M $-6.1M $-2.8M
Net Margin -111.4% -184.2% — —
EPS (Basic) $-2.01 $-2.13 $-0.64 $-0.60
EPS (Diluted) $-2.01 $-2.13 $-0.64 $-0.60
Shares Outstanding (Basic) 10.5M 6.7M 9.5M 6.5M
Shares Outstanding (Diluted) 10.5M 6.7M 9.5M 6.5M
Dividends Per Share — — — —